Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® Tablet
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to investigate the safety and efficacy information of Alesion® Tablet under the proper
use in daily clinical practice after new treatment guideline for allergic rhinitis, bronchial
asthma, eczema, dermatitis, urticaria, pruritus, prurigo and psoriasis vulgaris with itching